MMRF, Onyx enter collaboration for multiple myeloma treatment
MMRF’s Personalized Medicine Initiative has been developed to allow molecular characterization of multiple myeloma patients and thus enforce the development of new, targeted treatments. Onyx is believed to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.